In this case, dietary FSO increased the suppressing effect of Trastuzumab on tumor growth by interacting with Trastuzumab to suppress p-HER2, p-ERK-2, and p-AKT1 expression [46]. This evidence concerns the gene ERBB2 and neoplasm.